Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planus pigmentosus is hard to treat and may be more common in North Africa than previously thought.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

Recognizing skin symptoms helps diagnose and treat frontal fibrosing alopecia.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Frontal fibrosing alopecia is a complex condition with no definitive treatment.

Patients with Frontal fibrosing alopecia in Morocco often have skin conditions and thyroid disorders.

The exact cause of frontal fibrosing alopecia is unknown, but it's not likely due to sunscreen.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Mitochondrial dysfunction and oxidative stress may play a role in Lichen Planopilaris.

Some people with lichen planus pigmentosus might later develop frontal fibrosing alopecia.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Trichoscopy helps tell apart Lichen planopilaris and Frontal fibrosing alopecia from other hair loss conditions.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Avoiding allergens can improve skin and hair conditions in adults with allergic reactions.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

The critique highlights an error in a review about hair loss treatment, stressing the need for accurate information and caution due to poor evidence quality.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.